Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Bending, Not Breaking

Philip Seo, MD, MHS  |  Issue: August 2019  |  August 16, 2019


Philip Seo, MD, MHSPhilip Seo, MD, MHS, is an associate professor of medicine at the Johns Hopkins University School of Medicine, Baltimore. He is director of both the Johns Hopkins Vasculitis Center and the Johns Hopkins Rheumatology Fellowship Program.

References

  1. Rawson NSB, Binder L. Importation of drugs into the United States from Canada. CMAJ. 2017 Jun 10;189(24):E817–E818.
  2. U.S. Food & Drug Administration. Is it legal for me to personally import drugs? As of 2018 Mar 28.
  3. CanaRx.
  4. Sexton C. Canadian drug imports could get go-ahead in Florida Senate. Orlando Sentinel. 2019 Apr 26.
  5. Eason B. Colorado wants to import prescription drugs from Canada. How it could work, and why it may not. The Colorado Sun. 2019 Mar 19.
  6. The New York Times Editorial Board. Use Medicare’s muscle to lower drug prices, opinion. The New York Times. 2015 Sep 21.
  7. Leonard K. Alex Azar fires back at critics of drug pricing plan: ‘The president is doing exactly what he said.’ Washington Examiner. 2018 May 14.
  8. Galewitz P. Importing prescription drugs has Trump’s endorsement: Will more states follow? USA Today. 2019 Jun 24.
  9. U.S. Department of Health & Human Services. National Institutes of Health. U.S. National Library of Medicine. National Information Center on Health Services Research and Health Care Technology (NICHSR). HTA 101: Introduction to health technology assessment.
  10. Challenge of non-interference. The National Law Review. 2016 Jan 29.
  11. Hall CT. Kaiser won’t cover cost of Viagra/It cites huge price tag—over $100 million a year. SF Gate. 1998 Jun 19.
  12. Maniace L. How do I know if an online pharmacy is legitimate? Consumer Reports. 2011 Oct 27.
  13. FDA operations reveal many drugs promoted as ‘Canadian’ products really originate from other countries. FDA. 2005 Dec 16.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:EthicsOpinionRheuminationsSpeak Out Rheum Tagged with:Canadian drugsdrug costs

Related Articles

    A Comparison of the Canadian and U.S. Healthcare Systems

    February 3, 2012

    The joys and the hazards of the Canadian single-payer universal healthcare program Canadian and the high-capacity and costly U.S. healthcare system.

    Value-Based Purchasing: The Future of US HealthCare?

    August 1, 2009

    Purchasers of healthcare are beginning to take a more active role in ensuring they receive value for their health care dollars, and these savvy shoppers want to develop programs to increase the quality and efficiency of the care they purchase. This movement has given rise to the concept of value-driven healthcare, commonly called value-based purchasing. Over the next three months, “From the College” will take a look at this type of purchasing and provide rheumatologists and rheumatology health professionals with practical advice on how to stand out to these value-based purchasers.

    garagestock/shutterstock.com

    E-Health, Telemedicine Pose Challenges, Offer Benefits for Patients with Arthritis

    August 11, 2016

    A 52-year-old woman comes to the office complaining of a two-month history of pain and swelling in the small joints of her hands, feet and knees. She says, “Doctor, I’ve been searching the Internet, and I think I have rheumatoid arthritis. I have some questions for you.” The healthcare system in the U.S. is changing…

    The Birth and Growth of Biotechnology, and the Impact of Biologic Drugs on Rheumatology

    June 15, 2017

    Here’s a trivia question: Where were the big ideas for the field of biotechnology first discussed? Answer: At a since-demolished delicatessen in Waikiki Beach, Hawaii. Go figure. The year was 1972, and Stanley Cohen, MD, professor of medicine at Stanford University in Palo Alto, Calif., and Herbert Boyer, PhD, a former professor and biochemist at the…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences